Dr. Lin is trained as a psychiatrist and a genetic epidemiologist. His research efforts have been devoted to the identification of biomarkers associated with clinical heterogeneity in neuropsychiatric diseases such as autism. Dr. Lin is currently working on solutions to classify subgroups of neurodevelopmental disorders for research on precision medicine.
Autism spectrum disorder (ASD) is characterized by heterogenous clinical presentations. Two different approaches were used to parsing through genetic underpinnings for clinical heterogeneity in ASD. The first approach is to identify extended haplotypes associated with the speech delay. The second is to use transcriptomic profiles to identify ASD subgroups that could predict language impairment using machine learning algorithms. These findings suggest that clinical heterogeneity may provide opportunities to discover novel genetic underpinnings for ASD.